|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables (net of allowances of $0.3 million and $11.1 million at September 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Properties, plants and equipment (net of accumulated depreciation of $1,554.2 million and $1,497.6 million at June 30, 2025 and December 31, 2024, respectively) | ||||||||||||||||||||
| Properties, plants and equipment (net of accumulated depreciation of $1,615.2 million and $1,497.4 million at September 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred charges and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current portion of financing obligation | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrual for black lung benefits | ||||||||||||||||||||
| Retirement benefit liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Asset retirement obligations | ||||||||||||||||||||
| Long-term financing lease liability | ||||||||||||||||||||
| Other deferred credits and liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value. Authorized 50,000,000 shares; no issued shares at both September 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.01 par value. Authorized 300,000,000 shares; issued 100,279,332 and 100,069,991 shares at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Treasury stock, 15,404,482 shares at both September 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total SunCoke Energy, Inc. stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
